Polymerase chain reaction with allele-specific oligonucleotides (ASO-PCR) is a technique that can discriminate low levels of the mutant sequence against a background high in wild-type DNA. 14 In ...
Table 1 Association of the MyD88 rs6853 and TIRAP rs8177374 polymorphic sites with pulmonary tuberculosis. Exploratory study in an Italian population sample The logistic regression model was also used ...
In a recent study published in the Journal of Experimental Medicine, researchers identified that individuals with a deficiency of myeloid differentiation primary response 88 (MyD88) and interleukin-1 ...
Brukinsa achieved higher complete or very good partial response rates than Imbruvica in MYD88-mutated Waldenström macroglobulinemia patients. Brukinsa demonstrated faster response times and more ...
Researchers have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Researchers have described ...
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom macroglobulinemia. This is an ASCO Meeting Abstract from the 2012 ASCO ...
Fractionated dose radiolabeled anti−prostate specific membrane antigen (PSMA) radioimmunotherapy (177Lu−J591) for progressive metastatic castration−resistant prostate cancer (mCRPC). Comorbidity and ...
BioWorld - Tuesday, February 3, 2026 Breaking News: BioWorld Science 2025 Year in Review See today's BioWorld Science Home » MyD88 inhibitor with improved drug-like properties, anti-inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results